Home › Blood Cancers › Michigan
Blood Cancers clinical trials in Michigan
22 studies for Blood Cancers are looking for participants at sites in Michigan.
Cities in Michigan
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- University of Michigan Health System, Ann Arbor
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT04634552A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
- Start Midwest, Grand Rapids
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07572006Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 22, Ann Arbor
RecruitingPhase 3
Ages 18 to 71 · All sexes · Updated Sep 23, 2026 · NCT07504458Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- MyMichigan Medical Center Gratiot, Alma
- MyMichigan Medical Center Alpena, Alpena
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- and 33 more
RecruitingObservational study
All ages · All sexes · Updated Sep 17, 2026 · NCT04242095Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Karmanos Cancer Institute ( Site 0047), Detroit
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT03486873A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- University of Michigan, Ann Arbor
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07195916Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MyMichigan Medical Center Gratiot, Alma
- MyMichigan Medical Center Alpena, Alpena
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- and 71 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Karmanos Cancer Institute, Detroit
- Henry Ford Cancer Institute, Detroit
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT06001788Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- University of Michigan, Ann Arbor
- Wayne State University School of Medicine, Detroit
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07007312A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
- University of Michigan, Ann Arbor
- START Midwest, Grand Rapids
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT06823167PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
- Barbara Ann Karmanos Cancer Institute, Detroit
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT06665100A Study of APG-3288 in Relapsed/Refractory Blood Cancers
- START Midwest, Grand Rapids
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT07424833A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Michigan, Ann Arbor
- Children's Hospital of Michigan, Detroit
- Henry Ford Health System, Detroit
- and 2 more
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
- Uni Of Michigan Health System, Ann Arbor
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT06401356Increasing Knowledge and Interest in Cancer Clinical Trials
- Wayne State University/Karmanos Cancer Institute, Detroit
RecruitingHealthy volunteers welcome
Ages 21 and older · All sexes · Updated Jun 10, 2026 · NCT06501040Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
- West Michigan Cancer Center, Kalamazoo
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 7, 2026 · NCT02269592A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
- Children's Hospital of Michigan, Detroit
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated May 5, 2026 · NCT05711667A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Karmanos Cancer Institute, Detroit
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT05735184HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
- Henry Ford hospital, Detroit
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Feb 24, 2026 · NCT03850366Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
- Karmanos Cancer Institute, Detroit
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 11, 2026 · NCT07036133A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
- Corewell Health, Grand Rapids
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 25, 2025 · NCT05768269Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- C.S. Mott Children's Hospital, Ann Arbor
RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.